Pfizer Unusual Options Activity - Pfizer (NYSE:PFE)

Investors with a lot of money to spend have taken a bearish stance on Pfizer PFE.

And retail traders should know.

We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PFE, it often means somebody knows something is about to happen.

So how do we know what these investors just did?

Today, Benzinga's options scanner spotted 12 uncommon options trades for Pfizer.

This isn't normal.

The overall sentiment of these big-money traders is split between 25% bullish and 58%, bearish.

Out of all of the special options we uncovered, 4 are puts, for a total amount of $172,875, and 8 are calls, for a total amount of $675,260.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $32.5 for Pfizer over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for Pfizer options trades today is 11219.62 with a total volume of 2,269.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Pfizer's big money trades within a strike price range of $20.0 to $32.5 over the last 30 days.

Pfizer Option Volume And Open Interest Over Last 30 Days

Significant Options Trades Detected:

Symbol	PUT/CALL	Trade Type	Sentiment	Exp. Date	Ask	Bid	Price	Strike Price	Total Trade Price	Open Interest	Volume
PFE	CALL	SWEEP	BEARISH	06/18/26	$7.0	$4.25	$4.25	$27.00	$255.1K	3.7K	400
PFE	CALL	TRADE	BULLISH	06/18/26	$4.35	$4.25	$4.35	$27.00	$173.9K	3.7K	0
PFE	PUT	SWEEP	BEARISH	06/21/24	$5.45	$5.3	$5.45	$32.50	$59.8K	11.9K	168
PFE	CALL	SWEEP	BEARISH	01/16/26	$3.0	$2.7	$2.7	$30.00	$54.7K	31.1K	18
PFE	CALL	TRADE	BEARISH	07/19/24	$1.65	$1.54	$1.54	$27.00	$46.2K	7.6K	8

About Pfizer

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Current Position of Pfizer

With a trading volume of 1,442,102, the price of PFE is up by 0.18%, reaching $27.23.
Current RSI values indicate that the stock is may be approaching overbought.
Next earnings report is scheduled for 89 days from now.

Expert Opinions on Pfizer

3 market experts have recently issued ratings for this stock, with a consensus target price of $45.0.

An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $45.
An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $45.
Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Pfizer options trades with real-time alerts from Benzinga Pro.

Market News and Data brought to you by Benzinga APIs